Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.2, then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 6 contracts
Samples: License Agreement (Spectrum Pharmaceuticals Inc), License Agreement, License Agreement
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.2, then the Non-Breaching breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 4 contracts
Samples: Commercial License Agreement (Sage Therapeutics, Inc.), Commercial License Agreement (Sage Therapeutics, Inc.), Commercial License Agreement (Sage Therapeutics, Inc.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.29.2, then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 4 contracts
Samples: Supply Agreement (Sage Therapeutics, Inc.), Supply Agreement, Supply Agreement (Sage Therapeutics, Inc.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.213.2(a), then the Non-Breaching Party may terminate this Agreement immediately upon written notice to the Notified Party.
Appears in 2 contracts
Samples: License Agreement (BioLineRx Ltd.), License Agreement (Cypress Bioscience Inc)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.211.2, then the Non-Breaching breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 2 contracts
Samples: License and Supply Agreement (Ligand Pharmaceuticals Inc), License and Supply Agreement (Ligand Pharmaceuticals Inc)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.211.2(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 2 contracts
Samples: License Agreement (Celladon Corp), License Agreement (Celladon Corp)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.29.2(b), then the Non-Breaching breaching Party may terminate this Agreement either in its entirety or with respect to one or more Products upon written notice to the Notified Party.
Appears in 2 contracts
Samples: Asset Purchase (Cavit Sciences, Inc.), Royalty Agreement (Cavit Sciences, Inc.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.210.4(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 2 contracts
Samples: License Agreement, License Agreement (Portola Pharmaceuticals Inc)
Failure to Cure. If the Notified Party fails to cure a material such breach of this Agreement as provided for in Section 13.213.4(a), then the Non-Breaching breaching Party may terminate this Agreement either in its entirety or with respect to one or more Licensed Products upon written notice to the Notified Party, provided that, the Non-breaching Party gives such written notice of termination within [*] after the Notified Party has failed to cure such breach as provided for in Section 13.4(a).
Appears in 2 contracts
Samples: License Agreement (Cubist Pharmaceuticals Inc), License Agreement (Cubist Pharmaceuticals Inc)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.28.2(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 2 contracts
Samples: Supply Agreement (Spectrum Pharmaceuticals Inc), Supply Agreement (Ligand Pharmaceuticals Inc)
Failure to Cure. If the Notified Party fails to cure a material such breach of this Agreement as provided for in Section 13.214.3(a), then the Non-Breaching breaching Party may terminate this Agreement either in its entirety or with respect to one or more Licensed Products upon written notice to the Notified Party; provided, however, that alleged breaches by either Party of its Diligence Obligations pursuant to Section 3.1 or 5.5 shall be handled initially as provided in Section 3.5 or 5.6.
Appears in 1 contract
Samples: Marketing, Distribution and Development Agreement (Gilead Sciences Inc)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.28.2, then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 1 contract
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.213.2.1, then the Non-Breaching Party may terminate provide notice of termination of this Agreement in its entirety immediately upon written such failure, which notice to the Notified Partyshall take effect immediately upon delivery.
Appears in 1 contract
Samples: License Agreement (GPC Biotech Ag)
Failure to Cure. If the Notified Party fails to cure a material such breach of this Agreement as provided for in Section 13.215.2(a), then the Non-Breaching breaching Party may terminate this Manufacturing Agreement either in its entirety or with respect to one or more Products upon written notice to the Notified Party.
Appears in 1 contract
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in this Section 13.28.2, then the Non-Breaching Party may terminate this Agreement immediately upon written notice to the Notified Party.
Appears in 1 contract
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.212.2.1, then the Non-Breaching Party may terminate this Agreement immediately upon written notice to the Notified Party.
Appears in 1 contract
Samples: Investment and Collaboration Agreement (BioLineRx Ltd.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.28.2(a), then the Non-Breaching breaching Party may terminate this Agreement either in its entirety or with respect to one or more Products upon written notice to the Notified Party.
Appears in 1 contract
Failure to Cure. If the Notified Party fails to cure a material the breach of this Agreement as provided for in Section 13.213.2(a), then the Non-Breaching Party may terminate this Agreement immediately upon written notice to the Notified Party.
Appears in 1 contract
Samples: Technology License Agreement (Oramed Pharmaceuticals Inc.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.213.2(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 1 contract
Samples: License Agreement (Tranzyme Inc)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for in Section 13.29.4(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 1 contract
Samples: License and Collaboration Agreement (Signal Genetics, Inc.)
Failure to Cure. If the Notified Party fails to cure a material breach of this Agreement as provided for and within the time period set forth in Section 13.210.3(a), then the Non-Breaching Party may terminate this Agreement upon written notice to the Notified Party.
Appears in 1 contract